Published in PLoS One on February 27, 2012
Direct involvement of retinoblastoma family proteins in DNA repair by non-homologous end-joining. Cell Rep (2015) 0.92
A kinome-targeted RNAi-based screen links FGF signaling to H2AX phosphorylation in response to radiation. Cell Mol Life Sci (2015) 0.76
Workflow for high-content, individual cell quantification of fluorescent markers from universal microscope data, supported by open source software. J Vis Exp (2014) 0.75
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen (1999) 32.67
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (1998) 17.91
p21 is a universal inhibitor of cyclin kinases. Nature (1993) 15.55
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (1993) 13.68
Cell-cycle checkpoints and cancer. Nature (2004) 13.19
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat (2007) 12.98
Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev (2000) 11.49
DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet (2001) 10.77
A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell (2009) 8.64
Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science (1997) 8.24
DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science (2000) 7.85
Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol (2008) 6.62
Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell (1992) 6.08
Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev (2000) 5.90
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev (2000) 5.72
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol (2003) 5.46
Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer (2008) 5.19
DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev (1994) 4.64
Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell (2004) 4.39
Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc Natl Acad Sci U S A (2002) 4.06
Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol (1998) 3.88
Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer (2005) 3.58
Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol (2009) 3.15
Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nat Rev Cancer (2004) 3.06
p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci U S A (1994) 2.63
The combined status of ATM and p53 link tumor development with therapeutic response. Genes Dev (2009) 2.56
pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci U S A (1998) 2.49
Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair (Amst) (2004) 2.39
MEKK1/JNK signaling stabilizes and activates p53. Proc Natl Acad Sci U S A (1998) 2.27
Regulation of mitotic entry by microcephalin and its overlap with ATR signalling. Nat Cell Biol (2006) 2.20
Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc Natl Acad Sci U S A (1999) 2.10
DNA damage checkpoints in mammals. Mutagenesis (2005) 2.05
Mapping of MST1 kinase sites of phosphorylation. Activation and autophosphorylation. J Biol Chem (2002) 1.97
Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint. Mol Cancer Ther (2003) 1.90
p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol Cell Biol (2009) 1.88
Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev (2000) 1.80
DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization. Mol Cell (2010) 1.78
Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas-induced apoptosis. J Biol Chem (2001) 1.76
Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol Cell Biol (2003) 1.71
Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response. Mol Cell Biol (2004) 1.63
Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol Cell Biol (2001) 1.54
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics. Int J Cancer (2006) 1.53
Exploiting synthetic lethal interactions for targeted cancer therapy. Cell Cycle (2009) 1.44
Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner. J Biol Chem (2000) 1.43
Death-associated protein 4 binds MST1 and augments MST1-induced apoptosis. J Biol Chem (2002) 1.41
Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene (1995) 1.34
A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev (2011) 1.30
p53 Signaling and cell cycle checkpoints. Chem Res Toxicol (2001) 1.26
Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc Natl Acad Sci U S A (1995) 1.23
Complexity of damage produced by ionizing radiation. Cold Spring Harb Symp Quant Biol (2000) 1.23
Dealing with DNA damage: relationships between checkpoint and repair pathways. Mutat Res (2009) 1.22
MST kinases monitor actin cytoskeletal integrity and signal via c-Jun N-terminal kinase stress-activated kinase to regulate p21Waf1/Cip1 stability. Mol Cell Biol (2009) 1.20
Cell cycle-dependent regulation of a human DNA helicase that localizes in DNA damage foci. Mol Biol Cell (2004) 1.20
Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism. EMBO J (2004) 1.15
Cloning and characterization of a p53-related protein kinase expressed in interleukin-2-activated cytotoxic T-cells, epithelial tumor cell lines, and the testes. J Biol Chem (2001) 1.05
The limitations of the G1-S checkpoint. Cancer Res (2010) 1.02
The retinoblastoma family: twins or distant cousins? Genome Biol (2002) 1.02
Advances in radiation oncology. Annu Rev Med (2006) 1.00
Hypoxic stress induces reversible hypophosphorylation of pRB and reduction in cyclin A abundance independent of cell cycle progression. Oncogene (1993) 0.98
Enhancing radiosensitivity: targeting the DNA repair pathways. Cancer Biol Ther (2009) 0.98
RB activation defect in tumor cell lines. Proc Natl Acad Sci U S A (2002) 0.96
Role of the retinoblastoma tumor suppressor in the maintenance of genome integrity. Curr Mol Med (2006) 0.96
A chemosensitization screen identifies TP53RK, a kinase that restrains apoptosis after mitotic stress. Cancer Res (2010) 0.95
A reciprocal relationship between Rb and Skp2: implications for restriction point control, signal transduction to the cell cycle and cancer. Cell Cycle (2007) 0.94
Cyclin D1 degradation enhances endothelial cell survival upon oxidative stress. FASEB J (2006) 0.92
Phosphorylation of cyclin D1 regulated by ATM or ATR controls cell cycle progression. Mol Cell Biol (2008) 0.91
The genetic basis of tissue responses to ionizing radiation. Br J Radiol (2007) 0.90
Cell cycle dependent effects of u.v.-radiation on p53 expression and retinoblastoma protein phosphorylation. Oncogene (1995) 0.89
Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer. Clin Cancer Res (1997) 0.89
Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells. Oncogene (1996) 0.89
Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys (2001) 0.86
Initiation of high frequency multi-drug resistance following kinase targeting by siRNAs. Cell Cycle (2007) 0.85
p53 and Rb immunostaining in locally advanced bladder cancer: relation to prognostic variables and predictive value for the local response to radical radiotherapy. Eur Urol (1995) 0.83
Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer. Br J Cancer (2003) 0.82
Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy. J Cancer Res Ther (2009) 0.82
Role of retinoblastoma gene product in p53-mediated DNA damage response. Exp Cell Res (1994) 0.81
ATM is required for rapid degradation of cyclin D1 in response to gamma-irradiation. Biochem Biophys Res Commun (2008) 0.81
Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation. Future Oncol (2010) 0.80
A humble hexose monophosphate pathway metabolite regulates short- and long-term control of lipogenesis. Proc Natl Acad Sci U S A (2003) 0.80
Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics. Semin Oncol (2009) 0.79
p53-dependent G(1) arrest in 1st or 2nd cell cycle may protect human cancer cells from cell death after treatment with ionizing radiation and Chk1 inhibitors. Cell Prolif (2010) 0.79
Radiation oncology: overview and recent advances. J R Coll Physicians Edinb (2010) 0.76
Brain environment interactions: stress, posttraumatic stress disorder, and the need for a postmortem brain collection. Psychiatry (2004) 5.29
NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis. Cancer Res (2008) 2.76
Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc Natl Acad Sci U S A (2013) 2.30
Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis (2013) 2.21
Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. J Neurosci (2003) 2.20
Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol (2002) 2.19
N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci (2008) 2.18
A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription. Cancer Res (2010) 2.05
Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms. Chem Biol (2004) 1.80
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet (2013) 1.79
Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange. EMBO J (2006) 1.77
Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation. Proc Natl Acad Sci U S A (2003) 1.68
4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer. J Med Chem (2007) 1.67
Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Cancer Res (2007) 1.66
Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein response. EMBO J (2011) 1.65
A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors. Clin Cancer Res (2011) 1.61
Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. J Neurosci (2002) 1.48
High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity. Anal Biochem (2004) 1.42
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet (2012) 1.41
Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease. Hum Mol Genet (2005) 1.39
Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol Cell Neurosci (2009) 1.35
Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc. J Biol Chem (2008) 1.34
TERT regulates cell survival independent of telomerase enzymatic activity. Oncogene (2002) 1.31
Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala. Neuropsychopharmacology (2004) 1.27
Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family. Ann N Y Acad Sci (2007) 1.21
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues. Mol Cancer Ther (2007) 1.19
Stress impairs 5-HT2A receptor-mediated serotonergic facilitation of GABA release in juvenile rat basolateral amygdala. Neuropsychopharmacology (2008) 1.17
Rhesus macaque rhadinovirus-associated non-Hodgkin lymphoma: animal model for KSHV-associated malignancies. Blood (2008) 1.17
Construction of an infectious rhesus rhadinovirus bacterial artificial chromosome for the analysis of Kaposi's sarcoma-associated herpesvirus-related disease development. J Virol (2007) 1.16
Adductomics: characterizing exposures to reactive electrophiles. Toxicol Lett (2011) 1.16
Bidirectional modulation of GABA release by presynaptic glutamate receptor 5 kainate receptors in the basolateral amygdala. J Neurosci (2003) 1.16
CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes. Hepatology (2009) 1.16
Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors. Clin Cancer Res (2008) 1.14
Role of cyclic strain frequency in regulating the alignment of vascular smooth muscle cells in vitro. Biophys J (2007) 1.11
Dysregulated mitochondrial genes and networks with drug targets in postmortem brain of patients with posttraumatic stress disorder (PTSD) revealed by human mitochondria-focused cDNA microarrays. Int J Biol Sci (2008) 1.11
GAPDH: a common enzyme with uncommon functions. Clin Exp Pharmacol Physiol (2012) 1.10
Retracted V alpha 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement. J Immunol (2005) 1.10
Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture. Mol Cell (2007) 1.09
Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments. Hum Mol Genet (2010) 1.08
Application of meso scale technology for the measurement of phosphoproteins in human tumor xenografts. Assay Drug Dev Technol (2007) 1.08
In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitors. Cancer Res (2007) 1.07
Disrupted topological organization in white matter structural networks in amnestic mild cognitive impairment: relationship to subtype. Radiology (2012) 1.06
Selective ablation of retinoblastoma protein function by the RET finger protein. Mol Cell (2005) 1.05
A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. J Natl Cancer Inst (2013) 1.04
CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors. Cancer Res (2011) 1.04
Adult raphe-specific deletion of Lmx1b leads to central serotonin deficiency. PLoS One (2011) 1.03
Attenuation of disease phenotype through alternative translation initiation in low-penetrance retinoblastoma. Hum Mutat (2007) 1.03
Individual differences in false memory from misinformation: cognitive factors. Memory (2010) 1.02
Purification and characterization of a novel pyrethroid hydrolase from Aspergillus niger ZD11. J Agric Food Chem (2005) 1.01
Genetics of Sjögren's syndrome in the genome-wide association era. J Autoimmun (2012) 1.01
Serotonin transporter gene-linked polymorphic region (5-HTTLPR) influences decision making under ambiguity and risk in a large Chinese sample. Neuropharmacology (2010) 1.01
Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation. J Am Chem Soc (2008) 1.01
Notch activation enhances the microglia-mediated inflammatory response associated with focal cerebral ischemia. Stroke (2011) 1.01
Genetic analyses of interferon pathway-related genes reveal multiple new loci associated with systemic lupus erythematosus. Arthritis Rheum (2011) 1.01
Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension. FASEB J (2002) 1.00
Antioxidant properties of the mung bean flavonoids on alleviating heat stress. PLoS One (2011) 0.99
Prevalence of amblyopia and strabismus in a population of 7th-grade junior high school students in Central China: the Anyang Childhood Eye Study (ACES). Ophthalmic Epidemiol (2014) 0.99
Intravoxel incoherent motion MRI: emerging applications for nasopharyngeal carcinoma at the primary site. Eur Radiol (2014) 0.99
Highly efficient nonprecious metal catalysts towards oxygen reduction reaction based on three-dimensional porous carbon nanostructures. Chem Soc Rev (2015) 0.99
PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells. J Cell Sci (2013) 0.98
Design, methodology and baseline data of a school-based cohort study in Central China: the Anyang Childhood Eye Study. Ophthalmic Epidemiol (2013) 0.97
Histone modification enzymes: novel targets for cancer drugs. Expert Opin Emerg Drugs (2004) 0.97
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenografts. Neoplasia (2008) 0.97
RB activation defect in tumor cell lines. Proc Natl Acad Sci U S A (2002) 0.96
Isolation and characterization of genomic retrotransposon sequences from octoploid strawberry (Fragaria x ananassa Duch.). Plant Cell Rep (2007) 0.96
Direct interaction between the catalytic subunit of Protein Phosphatase 1 and pRb. Cancer Cell Int (2006) 0.96
p53-Driven apoptosis limits centrosome amplification and genomic instability downstream of NPM1 phosphorylation. Nat Cell Biol (2008) 0.96
Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases. Brain Res Rev (2008) 0.96
Telomerase in cancer immunotherapy. Biochim Biophys Acta (2009) 0.96
Nanopyramid structure for ultrathin c-Si tandem solar cells. Nano Lett (2014) 0.95
Posttraumatic stress disorder and traumatic stress: from bench to bedside, from war to disaster. Ann N Y Acad Sci (2010) 0.95
The physiological role of kainate receptors in the amygdala. Mol Neurobiol (2004) 0.94
Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor. Neuro Oncol (2010) 0.94
Docetaxel, cisplatin and fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysis. PLoS One (2013) 0.93
The phosphoinositide-specific phospholipase C inhibitor U73122 (1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione) spontaneously forms conjugates with common components of cell culture medium. Drug Metab Dispos (2007) 0.93
Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat. J Neuroimmune Pharmacol (2009) 0.93
Intracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas. Biomaterials (2013) 0.93
Stress-induced change of mitochondria membrane potential regulated by genomic and non-genomic GR signaling: a possible mechanism for hippocampus atrophy in PTSD. Med Hypotheses (2006) 0.92
Potential roles for estrogen regulation of telomerase activity in aging. Ann N Y Acad Sci (2007) 0.92
Sex modulates the associations between the COMT gene and personality traits. Neuropsychopharmacology (2011) 0.92
Electrochemical sensors and biosensors based on nanomaterials and nanostructures. Anal Chem (2014) 0.92
Telomere protein complexes and interactions with telomerase in telomere maintenance. Front Biosci (Landmark Ed) (2011) 0.92
MicroRNA-277 modulates the neurodegeneration caused by Fragile X premutation rCGG repeats. PLoS Genet (2012) 0.92
Molecular cloning, purification, and biochemical characterization of a novel pyrethroid-hydrolyzing esterase from Klebsiella sp. strain ZD112. J Agric Food Chem (2006) 0.92
Retrotransposon activation contributes to fragile X premutation rCGG-mediated neurodegeneration. Hum Mol Genet (2011) 0.92
Satb2 is required for dendritic arborization and soma spacing in mouse cerebral cortex. Cereb Cortex (2011) 0.91
Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders. J Psychiatr Res (2009) 0.91
Seasonal dynamics of phytoplankton in relation to key aquatic habitat factors in a polluted urban small water body in Tianjin, China. Bull Environ Contam Toxicol (2009) 0.91
P11 (S100A10) as a potential biomarker of psychiatric patients at risk of suicide. J Psychiatr Res (2010) 0.91
Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J Clin Endocrinol Metab (2002) 0.91
p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma. Oncogene (2002) 0.91
The injury profile after the 2008 earthquakes in China. Injury (2008) 0.91
Regulation of telomerase activity by apparently opposing elements. Ageing Res Rev (2010) 0.91
Structural and functional analysis of natrin, a venom protein that targets various ion channels. Biochem Biophys Res Commun (2006) 0.90
The presence of m1 to m5 receptors in human sclera: evidence of the sclera as a potential site of action for muscarinic receptor antagonists. Curr Eye Res (2006) 0.90
Regulation of microfilament organization by Kaposi sarcoma-associated herpes virus-cyclin.CDK6 phosphorylation of caldesmon. J Biol Chem (2005) 0.90
Notch1 signaling is activated in cells expressing embryonic stem cell proteins in human primary nasopharyngeal carcinoma. J Otolaryngol Head Neck Surg (2010) 0.90
Detection of the ATPase activity of the molecular chaperones Hsp90 and Hsp72 using the TranscreenerTM ADP assay kit. J Biomol Screen (2010) 0.90
Estrogen deficiency reversibly induces telomere shortening in mouse granulosa cells and ovarian aging in vivo. Protein Cell (2011) 0.90